News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Gallagher Carol Giltner
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/12/2023 |
4
| Gallagher Carol Giltner (Director) has filed a Form 4 on PMV Pharmaceuticals, Inc.|
Txns:
| Granted 21,500 options to buy
@ $5.59, valued at
$120.2k
Gifted 21,500 options to buy
@ $5.59, valued at
$120.2k
Gifted 21,500 options to buy
@ $5.59, valued at
$120.2k
|
|
| 06/02/2023 |
4
| Gallagher Carol Giltner (Director) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Granted 57,000 shares
@ $0
Granted 79,500 options to buy
@ $1.53, valued at
$121.6k
|
|
| 11/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/08/2022 |
3
| Gallagher Carol Giltner (Director) has filed a Form 3 on PMV Pharmaceuticals, Inc. |
| 08/17/2022 |
4
| Gallagher Carol Giltner (Director) has filed a Form 4 on Turning Point Therapeutics, Inc.|
Txns:
| Disposed/sold 8,500 options to buy
@ $65.39, valued at
$555.8k
Disposed/sold 8,500 options to buy
@ $65.64, valued at
$557.9k
Disposed/sold 30,000 options to buy
@ $39.99, valued at
$1.2M
|
|
| 06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2021 |
4
| Gallagher Carol Giltner (Director) has filed a Form 4 on Turning Point Therapeutics, Inc.|
Txns:
| Granted 8,500 options to buy
@ $65.64, valued at
$557.9k
|
|
| 12/17/2020 |
3/A
| Gallagher Carol Giltner (Director) has filed a Form 3/A on Frazier Lifesciences Acquisition Corp |
| 12/08/2020 |
3
| Gallagher Carol Giltner (Director) has filed a Form 3 on Frazier Lifesciences Acquisition Corp |
| 09/15/2020 |
3
| Gallagher Carol Giltner (Director) has filed a Form 3 on Metacrine, Inc. |
| 07/23/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/23/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/25/2019 |
4
| Gallagher Carol Giltner (Director) has filed a Form 4 on Turning Point Therapeutics, Inc.|
Txns:
| Granted 30,000 options to buy
@ $39.99, valued at
$1.2M
|
|
| 07/25/2019 |
3
| Gallagher Carol Giltner (Director) has filed a Form 3 on Turning Point Therapeutics, Inc. |
| 07/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2019 |
4
| Gallagher Carol Giltner (Director) has filed a Form 4 on Millendo Therapeutics, Inc.|
Txns:
| Granted 12,000 options to buy
@ $11.59, valued at
$139.1k
|
|
| 01/17/2019 |
4
| Gallagher Carol Giltner (Director) has filed a Form 4 on Millendo Therapeutics, Inc.|
Txns:
| Granted 6,000 options to buy
@ $8.8, valued at
$52.8k
|
|
| 12/11/2018 |
4
| Gallagher Carol Giltner (Director) has filed a Form 4 on Millendo Therapeutics, Inc.|
Txns:
| Granted 8,249 shares
@ $0
Granted 23,684 shares
@ $0 |
|
| 12/11/2018 |
3
| Gallagher Carol Giltner (Director) has filed a Form 3 on Millendo Therapeutics, Inc. |
| 11/07/2018 |
4
| Gallagher Carol Giltner (Director) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Sold 21,374 shares
@ $36.38, valued at
$777.6k
|
|
| 06/19/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/18/2018 |
4
| Gallagher Carol Giltner (Director) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Granted 1,500 shares
@ $0
Granted 5,000 options to buy
@ $45.65, valued at
$228.3k
|
|
| 05/16/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/20/2018 |
4
| Gallagher Carol Giltner (Director) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Sold 1,183 shares
@ $46.5, valued at
$55k
Exercised 1,548 restricted stock units
@ $0
Exercised 817 restricted stock units
@ $0 |
|
| 02/06/2018 |
4
| Gallagher Carol Giltner (Director) has filed a Form 4 on ANAPTYSBIO INC|
Txns:
| Granted 6,000 options to buy
@ $104.81, valued at
$628.9k
|
|
| 11/17/2017 |
4
| Gallagher Carol Giltner (Director) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Sold 1,184 shares
@ $14.2, valued at
$16.8k
Exercised 1,549 restricted stock units
@ $0
Exercised 817 restricted stock units
@ $0 |
|
| 08/17/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/12/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|
|